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Abstract  1 
In the developing mouse embryo, there are several waves of hematopoiesis. Primitive and 2 
definitive erythro-myeloid lineages appear prior to hematopoietic stem cell (HSC) emergence and 3 
these waves are considered to be transient, supporting embryonic homeostasis until HSC-derived 4 
hematopoiesis is established. However, recent evidence strongly supports that HSC-independent 5 
immune cells such as tissue macrophages and some innate lymphoid cells develop in the mouse 6 
embryo and persist into post natal life. Innate type B-1 cells have also been reported to emerge 7 
from hemogenic endothelial cells in the extra-embryonic yolk sac (YS) and para-aortic 8 
splanchnoleura (P-Sp), and continue to develop in the fetal liver even in HSC-deficient mouse 9 
embryos. This review examines B-1 cell development in the context of the layered immune system 10 
hypothesis of B lymphopoiesis and emergence of B-1 cells independent of HSC. 11 
 12 
 13 
 14 15 
3 
Hemogenic endothelial cell-derived hematopoiesis in the developing mouse embryo 1 
The first blood cells in the mouse embryo are observed in the embryonic day (E) 7.5 yolk sac 2 
(YS)1, 2. These blood cells are mainly large erythroblasts, expressing embryonic type hemoglobin 3 
molecules, and are called primitive erythrocytes. Primitive types of megakaryocyte and 4 
macrophage progenitors are also produced at this stage (primitive hematopoiesis). Around E8.0, 5 
erythroblasts that are much smaller than the primitive erythrocytes and express adult type 6 
hemoglobin molecules (definitive erythroid progenitors) are detectable together with myeloid cells 7 
arising from erythro-myeloid progenitor cells (EMPs). These EMPs are produced mainly in the 8 
YS3. Finally around E11, the first adult-repopulating HSCs are detectable within the aorta-gonado-9 
mesonephros (AGM) region4, 5. 10 
The first HSCs are considered to “bud” from endothelial cells (ECs) residing in the ventral 11 
side of the dorsal aorta that are called “hemogenic ECs”6-9.  Hemogenic ECs are blood-producing 12 
ECs and the evidence of their actual presence and function is provided by in vitro and in vivo 13 
assays10-15. For example, in vivo lineage tracing studies using vascular endothelial cadherin 14 
promoter driven Cre recombinase (VEcad-cre) bred to Rosa-yellow fluorescent protein (YFP) 15 
mice, all the hematopoietic cells in the adult bone marrow (BM) are YFP positive, indicating that 16 
all the blood cells were endothelial derived12, 15. Runx1 is a critical transcriptional factor for 17 
hematopoiesis. Runx1 knockout embryos die at E12.5 lacking detectable EMPs, blood cell 18 
budding in the dorsal aorta, and transplantable HSCs. When runx1 is deleted under the control of 19 
an endothelial specific VE-cadherin promoter, knockout embryos display similar phenotypes to 20 
total runx1 knockout embryos, such as loss of EMPs and HSCs, while runx1 deletion under a 21 
hematopoietic specific vav promoter does not influence EMP and HSC production. These results 22 
indicate that EMP and HSCs are derived from hemogenic ECs and that runx1 is indispensable 23 
for the endothelial-hematopoietic transition that occurs in E8 to E11.5 murine embryos12, 16. Of 24 
note, although primitive erythroblasts express runx1, primitive hematopoiesis is not affected by 25 
4 
runx1 deletion17. Whether primitive hematopoiesis is derived directly from mesoderm or from 1 
hemogenic EC is still a controversial topic2. 2 
Once HSCs emerge in the AGM region, these HSCs seed the fetal liver where they 3 
dramatically expand, and then migrate to spleen and BM just before birth. HSCs settle in the BM 4 
to maintain hematopoiesis throughout life, self-renewing and producing all blood cell lineages. 5 
 6 
A layered Immune system hypothesis and B-1 cell development 7 
As mentioned above, there are several waves of hematopoietic cell emergence during 8 
embryogenesis including primitive hematopoietic progenitors, EMPs, and HSCs. The first two 9 
waves (primitive and EMPs) are considered to be transient and not to contribute to postnatal 10 
hematopoiesis, however, recent studies have revealed that tissue macrophages are of fetal origin 11 
and are not replenished by adult HSC-derived monocytes during homeostasis18. Similarly, some 12 
lymphoid populations are considered to be of fetal origin, challenging the stem cell theory that all 13 
the lymphoid cells are derived from HSCs. 14 
The layered immune system hypothesis was proposed by Drs. Herzenberg and 15 
Herzenberg in 198919, attempting to explain why certain types of lymphoid cells were preferentially 16 
produced from fetal stem/progenitors, but not from adult stem/progenitor cells. In this model, there 17 
are at least 2 waves of B cell development during embryonic to neonatal periods; the first one is 18 
the development of CD5+ B cells, called B-1a cells, produced predominantly by fetal liver 19 
stem/progenitor cells. Following the first wave, the second wave of conventional B (B-2) cell 20 
development produced by HSCs starts at fetal liver stage. The second wave becomes 21 
predominant in the postnatal BM and lymphoid organs whereas the first wave wanes with 22 
advancing age. Thus, these 2 waves are over lapping, detectable at fetal liver stage (B-1>B-2), 23 
but seem to originate from different stem/progenitor cells arising at different times during 24 
development. B-1 cells are innate immune B cells that can be distinguished from conventional B-25 
2 cells in the peripheral lymphoid organs. B-1 cells mainly reside in the pleural and peritoneal 26 
5 
cavities and produce natural IgM antibodies against stereotypic antigens independent of T cell 1 
help. In addition to their specific surface markers (IgMhiIgDloCD11b+CD5+/-), one of the unique 2 
characteristics of B-1 cells is their different developmental pathway from conventional B-2 cells20. 3 
It has been recognized that B-1 cells are readily reconstituted by fetal liver progenitor cells upon 4 
transplantation, whereas adult BM cells do not repopulate this lineage. The “pro-B cell” 5 
(B220+CD43+) population isolated from E16 fetal liver reconstitutes CD5+ B-1a cells efficiently, 6 
but fails to produce B-2 cells in recipient mice upon transplantation, while the pro-B cell population 7 
from adult BM shows the opposite results21. In IL-7 knockout mice, B lymphopoiesis is observed 8 
exclusively in fetal and neonatal periods, but ceases after 7 weeks of age22.  The B cells found in 9 
IL-7 knockout mice belong to the peritoneal B-1 and splenic marginal zone B cell pools and persist 10 
throughout adult life without being replenished from BM derived B progenitor cells (as these 11 
progenitors are no longer present). Similarly, when Rag2 gene expression is ablated at birth in 12 
conditional knockout mouse, CD5+ B-1a cells in the peritoneal cavity and marginal zone B cells 13 
in the spleen are maintained although splenic Follicular (FO) B cells (known to represent B-2 14 
cells) are not produced23. These findings have supported the hypotheses that progenitors that 15 
give rise to CD5+ B-1a cells are present only in fetal and neonatal life, and that CD5+ B-1a cells 16 
display self-renewal properties. Identification of AA4.1+CD19+B220lo-neg B-1 specific progenitor 17 
cells in the fetal liver and neonatal BM support this hypothesis24. A recent report that a purified 18 
long-term adult HSC is unable to reconstitute B-1a cells upon single cell HSC transplantation has 19 
also given strong evidence for these hypotheses25. Interestingly, since the first phenotypic B-1 20 
progenitor cells are detectable at E10.5 in the AGM region, at a time when the first HSCs 21 
emerge26, this raises an intriguing question as to the origin of the B-1 progenitor cells; it would be 22 
impossible for a HSC (that has been just born) to self-renew/expand and differentiate into B-1 23 
progenitor cells simultaneously. We and others have hypothesized that precursor cells other than 24 
HSCs must have produced the B-1 progenitor cells prior to HSC emergence in order for both cell 25 
types to appear concomitantly. 26 
6 
 1 
Hemogenic endothelial origin of B-1 cells 2 
Evidence for B lymphoid potential detectable in the YS, para-aortic spranchnopleura (P-Sp, later 3 
called as AGM after E10) has been controversial: Cumano et al found B and T lymphoid potential 4 
only in the P-Sp and not YS prior to HSC emergence27. Yokota et al demonstrated Rag1+ lymphoid 5 
cell production from P-Sp Tie2+ endothelial cells (ECs), but not from YS CD41+ cells28. Nishikawa 6 
et al showed B and T lymphoid potential in CD45-VEcad+ ECs from both E9.5 YS and P-Sp11. 7 
Since circulation is already established as early as E8.25, such discrepant results have been 8 
attributed to the fact that the circulation may have mixed lymphoid progenitor cells derived from 9 
different hematopoietic tissues and obscured the site of origin of these cells. In order to clarify the 10 
temporal and spatial origin of the first B cells produced, we have utilized a Ncx1 knockout mouse 11 
model, where the embryonic heart develops normally but never begins beating29. While the lack 12 
of a heartbeat is embryonic lethal at E11, the embryos survive until E10.5 without any systemic 13 
blood cell circulation3. When E9 YS and P-Sp cells from wild type and Ncx1-/- embryos were plated 14 
on OP9 stromal cells that support B lymphopoiesis. AA4.1+CD19+B220dim B-1 progenitor cells 15 
were detected at 8 days of coculture, and by 14 days of culture, CD19+B220+ B cells were 16 
expanded from both wild type and Ncx1-/- YS and P-Sp. These CD19+B220+ cells matured into 17 
IgM+ B cells and secrete anti-phosphorylcholine antibodies (that are thought to be preferentially 18 
secreted by B-1 cells) in vitro. When YS/P-Sp derived CD19+B220+ cells were transferred into the 19 
peritoneal cavity of NOD/SCID/IL2γc-/- 2 day old neonates, these B cells matured into only 20 
peritoneal B-1 cells and splenic MZ B cells, but not B-2 cells. These AA4.1+CD19+B220+ cells 21 
were also produced from ECs as early as the 4-somite pair stage of YS and P-Sp development 22 
(before the heart normally begins beating). Importantly, these B cells were produced from 23 
VEcad+CD41- hemogenic ECs, but not from CD41+c-kit+ hematopoietic cells until the 26-somite 24 
pair stage, suggesting that the lymphoid progenitor cells were derived via an endothelial to 25 
hematopoietic transition. These findings demonstrated that the first wave of B cells belongs to the 26 
7 
B-1 cell lineage and are produced from hemogenic ECs in YS and P-Sp, prior to HSC 1 
emergence29. 2 
The layered immune system hypothesis has recently been updated by Drs. Montecino-3 
Rodriguez and Dorshkind30. They proposed that the first wave of B lymphopoiesis is comprised 4 
of YS/P-Sp hemogenic EC-derived B-1 cells, followed by a second wave of fetal liver 5 
HSC/progenitor-derived B cell production. In the second wave, B-1 lineage cells are mainly 6 
produced and B-2 lineage cell production initiates. In the third wave, BM HSCs produce 7 
predominantly B-2 lineages cells and the B-1 lineage cell production wanes along with aging. At 8 
the time this model was proposed, evidence for the first wave had been demonstrated only by in 9 
vitro culture and cultured cell transplantation, showing the “potential” of YS/P-Sp-derived cells to 10 
become B-1 precursors. In order to examine whether the first B-1 lineage production prior to HSC 11 
emergence is actually happening in vivo, we have utilized unique transgenic embryos that lack 12 
HSCs, but harbor EMP and a few B and T cells in the fetal liver31, 32. 13 
 14 
B-1 cells develop in the HSC deficient embryos. 15 
Core-binding factor beta (CBFβ) is the common non-DNA-binding subunit of the Cbf family of 16 
heterodimeric transcription factors and associates with CBFα subunits to increase the affinity of 17 
CBFα DNA-binding. CBFβ is required for CBFα2 (also called runx1) function and loss of CBFβ 18 
leads to embryonic lethality at E11-13, similar to runx1-/- embryos, displaying a severe deficiency 19 
of EMP and complete loss of HSCs31, 33. However, EMP formation and rare B and T cells were 20 
recovered in the fetal liver of Cbfβ-/- embryos when Cbfβ was expressed in Cbfβ-/- embryos under 21 
control of the endothelial Tek regulatory sequence as a transgene31, 32. Since Cbfβ-/-:Tek-22 
GFP/Cbfβ embryos survive for at least one day after birth and yet completely lack HSCs, we 23 
anticipated this complex transgenic murine system would be a great tool to analyze the phenotype 24 
and function of the B cell development that occurs in the absence of HSCs. We hypothesized that 25 
8 
the previously unclassified B cells found in the HSC-deficient Cbfβ-/-:Tek-GFP/Cbfβ fetal liver were 1 
cells of the B-1 lineage34. As expected, AA4.1+CD19+B220lo-neg B-1 specific progenitor cells were 2 
detected In the fetal liver and spleen of Cbfβ-/-:Tek-GFP/Cbfβ embryos. In wild type embryos, 3 
AA4.1+CD19+B220lo-neg B-1 progenitor cells become CD19+B220+CD43+ pro-B cells in the fetal 4 
liver, which subsequently differentiate into B-1 cells in the recipient peritoneal cavity upon 5 
transplantation21. However, in Cbfβ-/-:Tek-GFP/Cbfβ embryos, B220 was not up-regulated in 6 
AA4.1+CD19+ population and CD19+B220+CD43+ pro-B cells was not detected in the fetal liver 7 
throughout embryonic life, suggesting delayed maturation of B-1 progenitors in mutant embryos. 8 
When the fetal liver AA4.1+CD19+B220lo-neg cells from E17.5 wild type and mutant embryos were 9 
co-cultured with OP9 stromal cells with IL-7 and Flt3-ligand, wild type AA4.1+CD19+B220lo-neg cells 10 
expanded in 10 days up to 1M cells and matured into CD19+B220+ (and some IgM+) pro B cells. 11 
On the other hand, mutant AA4.1+CD19+B220lo-neg cells did not expand as much as wild type cells 12 
and it took 17 days to mature into CD19+B220+ pro B cells phenotype. In addition, most of the 13 
cells become Mac1+ myeloid cells instead of B cells. Since AA4.1+CD19+B220lo-neg B-1 progenitor 14 
cells are originally reported as myeloid-B-lymphoid biopotent progenitors35, the B cell potential in 15 
this population seems to be altered in mutant embryos. 16 
 When fetal liver mononuclear cells from wild type and Cbfβ-/-:Tek-GFP/Cbfβ embryos were 17 
transplanted into NOD/SCID/IL2γc-/- neonates, wild type fetal liver cells reconstituted all the 18 
myeloid, T, B cell lineages, including peritoneal B-1a, B-1b, B-2, and spleen FO, MZ, and B-1 19 
cells. On the other hand, Cbfβ-/-:Tek-GFP/Cbfβ fetal liver cells repopulated only peritoneal B-1a, 20 
B-1b and splenic MZ B cell at very low frequencies34. Since no B-2 and T cells were reconstituted, 21 
it was clear that no HSCs exist in Cbfβ-/-:Tek-GFP/Cbfβ embryos. 22 
 These data indicate that functional B-1 progenitor cells are present in the HSC-deficient 23 
fetal liver, but their expansion and maturation abilities seems to be impaired in Cbfβ-/-:Tek-24 
GFP/Cbfβ embryos. We hypothesized that this impairment may be due to the lack of Cbfβ 25 
9 
expression in B-1 progenitor cells. In Cbfβ-/-:Tek-GFP/Cbfβ embryos, Cbfβ expression is rescued 1 
only in TEK expressing ECs; once blood cells are produced from the TEK+ hemogenic EC, blood 2 
cells lose TEK and Cbfβ expression. In order to test this hypothesis, Cbfβ was overexpressed by 3 
retrovirus vector infection of Cbfβ-/-:Tek-GFP/Cbfβ fetal liver mononuclear cells and these cells 4 
were transplanted into NOD/SCID/IL2γc-/- neonates34. Cbfβ expression significantly improved B-5 
1 and MZ B cell engraftment of mutant fetal liver mononuclear cells up to 50% chimerism in the 6 
peritoneal cavity and spleen of recipient pups, but never rescued other lineages, such as B-2 or 7 
T cells, demonstrating that there were no HSCs in mutant fetal liver that could account for the 8 
observed results. These results also indicate that Cbfβ plays an important role in B-1 and MZ B 9 
cell development and expansion as reported in B-2 cells36.  10 
 Taken all together, we suggest that YS/P-Sp hemogenic ECs produce B-1 progenitors, 11 
which seed the fetal liver to develop into the B-1 cell lineage in the fetal liver and contribute to the 12 
postnatal B-1 cell pool (Fig.1). In order to elucidate how much of the B-1 cell pool are YS/P-Sp 13 
derived, lineage-tracing models would be required to discriminate the YS/P-Sp- and fetal liver 14 
HSC-derived B-1 cells during postnatal development. 15 
 16 
What kinds of lymphoid progenitors are produced at pre-HSC stage of mouse embryos? -17 
Lineage-restricted progenitors vs. multi-potent progenitors? 18 
Although B and T lymphoid potentials are detectable in YS and P-Sp at as early as E8.25 (4-6 sp 19 
stage)29, 37, whether these lymphoid cells are derived from multipotent progenitors or lineage-20 
restricted progenitors remains unknown. Before 26 sp, these B and T lymphoid cells are derived 21 
from CD41-CD45-VEcad+ hemogenic ECs, not from CD41+ or CD45+ hematopoietic cells34; thus 22 
this question is whether B and T lymphoid cells are derived from hemogenic ECs via multi-potent 23 
progenitors or lineage restricted progenitors (Fig. 2). A multipotent progenitor cell (MPP) that has 24 
a capacity of differentiation into erythro, myeloid, and lymphoid cells, but does not engraft in 25 
10 
recipient adult mice is first detectable in the E10 AGM region38, fetal liver39 and recently reported 1 
at late E9.5 YS40. In this sense, there are no MPPs reported before E9.5 stage, suggesting that 2 
these B and T lymphoid potentials are derived from lineage restricted progenitor cells before E9.5. 3 
Of note, these B and T lymphoid potentials are always observed with myeloid potential (although 4 
not by single cell assay). Thus, it is highly possible that B- or T- lineage-restricted progenitor cells 5 
directly differentiated from hemogenic EC that also retain myeloid potential.  6 
 In this sense, the myeloid and lymphoid lineage commitment branch is ambiguous during 7 
fetal hematopoiesis. A myeloid-based model has been previously suggested in 2001 by Drs. 8 
Katsura and Kawamoto41, where three types of progenitors retain myeloid potential in myelo-9 
lymphoid branches: myeloid-T-B-progenitors (p-MTB), myeloid-T progenitors (p-MT), and 10 
myeloid-B progenitors (p-MB). This model is based on the results of multi-lineage progenitor 11 
assays that allow clonal analysis of developmental potential of fetal liver progenitor cells using a 12 
modified fetal thymic organ culture (FTOC) system. When single E11.5 c-kit+CD45+ fetal liver cells 13 
are plated in the MLP assay culture, 6 types of progenitor cells were detected such as p-Multi 14 
(MTB), p-MT, p-MB, p-M, p-T, and p-B, demonstrating that lymphoid progenitors retain myeloid 15 
potential38, 39. Thus, this model is compatible with the B-1 progenitor cells that retain B-1 and 16 
myeloid potential as mentioned in the previous section. Similarly, Dr. Jacobsen’s group has 17 
reported the presence of Rag1+ Immune restricted progenitor cells that possess myelo-lymphoid 18 
potential (but not erythro-megakaryocyte potential) in the fetal liver42 and seem to be equivalent 19 
cell types to those reported by Drs. Katsura and Kawamoto’s group39. They have also shown 20 
Rag1cre+YFP+Mac1+ myeloid cells in the fetal liver: this population declines with advancing age, 21 
and is greatly diminished in the adult BM42. This result strongly implies that Rag1cre+YFP+Mac1+ 22 
myeloid cells may be derived from B-1 progenitor cells or bipotent myeloid-B progenitor cells in 23 
the fetal liver as previously reported35, 43. Interestingly a recent report has also demonstrated the 24 
presence of Rag1cre+YFP+Mac1+ myeloid cells in adult thymus44, supporting a myeloid-based 25 
model in the adult immune system as well. Thus, the relationship between myeloid and lymphoid 26 
11 
lineages is not straightforward as was previously thought45 especially in fetal hematopoiesis, and 1 
it would be interesting to understand how hemogenic ECs gain lymphoid or mulipotent potentials 2 
to produce immune lineage cells (Fig. 2). 3 
 4 
Summary 5 
We have reviewed the evidence for the layered immune system hypothesis of B cell development 6 
that includes the first wave of B-1 cell development derived from YS and P-Sp hemogenic ECs 7 
independent of any HSC contributions. Although the second wave of B cell production (dominant 8 
B-1 cell production) is considered to be fetal liver HSC-derived, recent data suggests that isolated 9 
and purified single fetal liver long-term HSC transplantation may not reconstitute the B-1a cell 10 
pool (presented by Dr. Ghosn at Merinoff World Congress 2014: B-1 cell Development and 11 
Function). Other questions also remain to be answered: What molecules are involved in B-1 cell 12 
lineage commitment? What is the precursor of the B-1 progenitor cells in the fetal liver stage other 13 
than hemogenic EC that emerge from the YS and P-Sp? How and where do fetal liver B-1 14 
progenitor cells mature into B-1a cells in vivo? Why does B-1 lineage potential in BM-derived 15 
HSC/CLP decline with advancing age? What types of cells are the counterpart of mouse B-1 cells 16 
in human subjects?  It is apparent that we have just begun to unravel the complex pathways for 17 
the developmental origins and life-long homeostatic maintenance of the innate immune B-1 cells 18 
in mice. We anticipate the information learned will enhance our fundamental understanding of the 19 
important immune defense roles played by B-1 cells and perhaps enlighten our understanding of 20 
human immune defenses, particularly following bone marrow transplantation46. 21 
 22 
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Figure legends 1 
Figure 1. The first and second waves of B-1 cell development in the mouse embryo. 2 
Hemogenic ECs in the YS/P-Sp produce B-1 progenitor cells prior to HSC emergence. These 3 
progenitor cells seed fetal liver (the first wave). Around at E11, the first HSCs emerge from 4 
hemogenic ECs at AGM region and also seed fetal liver and expand. Fetal liver B-1 progenitor 5 
cells derived from YS hemogenic EC (the first wave) and HSC (the second wave) mature into the 6 
peritoneal B-1 cells after birth.  7 
 8 
Figure 2. A hypothesis of hemogenic EC maturation and their production of various 9 
progenitor cells. 10 
In early stage of YS (E8-9.5), hemogenic ECs produce lineage restricted progenitors such as 11 
EMP, B/B-myeloid, and T/T-myeloid progenitor cells. Before E10, hemogenic ECs produce MPPs 12 
that can produce erythro-myeloid, lymphoid cells and these MPPs may mature into HSCs in vivo47. 13 
Also, hemogenic ECs at AGM region may further mature into HSC-producing ECs. 14 
  15 
17 
 1 
Figure 1 2 
  3 
18 
 1 
Figure 2 2 
 3 
